Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches

بواسطة Valent, Peter
منشور في 2007

On the safety of low-dose dasatinib in comorbid and non-comorbid patients: what is real-life? (Reply)

بواسطة Valent, Peter
منشور في 2011

Is there something wrong in paradise? Christian beliefs and the safety of novel BCR/ABL1 inhibitors

بواسطة Valent, Peter
منشور في 2011

Severe adverse events associated with the use of second-line BCR/ABL tyrosine kinase inhibitors: preferential occurrence in patients with comorbidities

بواسطة Valent, Peter
منشور في 2011

Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology

بواسطة Valent, Peter
منشور في 2013

Targeting the JAK2-STAT5 pathway in CML

بواسطة Valent, Peter
منشور في 2014

Risk Factors and Management of Severe Life-Threatening Anaphylaxis in Patients with Clonal Mast Cell Disorders

بواسطة Valent, Peter
الحاوية / القاعدة Clin Exp Allergy (2014)

KIT D816V and the cytokine storm in mastocytosis: production and role of interleukin-6

بواسطة Valent, Peter
الحاوية / القاعدة Haematologica (2020)

ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications

بواسطة Valent, Peter
الحاوية / القاعدة Pathobiology (2019)

BRD4: A BET(ter) target for the treatment of AML?

بواسطة Valent, Peter, Zuber, Johannes
منشور في 2014

Switching From High-Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report

بواسطة Füreder, Wolfgang, Valent, Peter
الحاوية / القاعدة Hemasphere (2020)

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms

بواسطة Hoermann, Gregor, Greiner, Georg, Valent, Peter
الحاوية / القاعدة Mediators Inflamm (2015)

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?

بواسطة Pleyer, Lisa, Valent, Peter, Greil, Richard
الحاوية / القاعدة Int J Mol Sci (2016)

Mastocytosis, MCAS, and Related Disorders—Diagnosis, Classification, and Therapy

بواسطة Niedoszytko, Marek, Valent, Peter, Nedoszytko, Bogusław
الحاوية / القاعدة Int J Mol Sci (2021)

Mast Cell Activation Syndrome: Proposed Diagnostic Criteria: Towards a global classification for mast cell disorders

بواسطة Akin, Cem, Valent, Peter, Metcalfe, Dean D.
منشور في 2010

Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts

بواسطة Valent, Peter, Akin, Cem, Metcalfe, Dean D.
الحاوية / القاعدة Blood (2017)

Mastocytosis: Immunophenotypical Features of the Transformed Mast Cells Are Unique Among Hematopoietic Cells

بواسطة Horny, Hans-Peter, Sotlar, Karl, Valent, Peter
الحاوية / القاعدة Immunol Allergy Clin North Am (2014)

The underestimated role of basophils in Ph(+) chronic myeloid leukaemia

بواسطة Valent, Peter, Horny, Hans‐Peter, Arock, Michel
الحاوية / القاعدة Eur J Clin Invest (2018)

Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia

بواسطة Berger, Angelika, Sexl, Veronika, Valent, Peter, Moriggl, Richard
الحاوية / القاعدة Oncotarget (2014)

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology

بواسطة Hoermann, Gregor, Greiner, Georg, Griesmacher, Andrea, Valent, Peter
الحاوية / القاعدة J Pers Med (2020)